Polaris Group, a pharmaceutical company, has appointed Robert Hoffman as chief financial officer (CFO). Hoffman has joined Polaris from Arena Pharmaceuticals, where he held senior financial positions for more than 13 years. Most recently, Hoffman was vice president of finance and CFO.
In his leadership roles, Hoffman contributed to the success of Arena’s initial public offering in 2000 and other equity, debt and collaborative transactions that totalled nearly US$1.5bn as Arena built a pipeline of drug candidates and completed a Phase 3 pivotal programme for its lead candidate.
Hoffman currently serves as a member of the Financial Accounting Standards Board’s (FASB) small business advisory committee and the steering committee of the Association of Bioscience Financial Officers. In addition, he is a member and former president of the San Diego chapter of Financial Executives International (FEI) and a director of the charitable organisation Day For Change. Hoffman earned a bachelor’s degree in business administration from St Bonaventure University.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more